Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.UK-based pharmaceutical marketing firm, Speciality European Pharma (SEP), has received a multi-million pound funding package from Clydesdale Bank which is believed to help SEP strengthen its market position in 2012.
Subscribe to our email newsletter
The funding package includes a £2.5m loan along with ancillary facilities for four years through to December 2015.
SEP is focused on marketing products related to urology and uro-oncology to treat various diseases including prostate cancer, bladder cancer and overactive bladder.
The company’s products are marketed directly in France, Germany, Italy and in the UK.